Hyderabad Telangana, India

Eswara Kowlakuntla

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biological E Limited. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eswara Kowlakuntla. Retrieved from https://idiyas.com/inventor/eswara-kowlakuntla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Eswara Kowlakuntla and His Contributions to Vaccine Development

Introduction: Eswara Kowlakuntla is an esteemed inventor based in Hyderabad, Telangana, India, recognized for his innovative work in the field of immunology. His notable contributions include the development of a pioneering semi-synthetic meningococcal conjugate vaccine, which holds significant potential for public health.

Latest Patents: Eswara Kowlakuntla holds one patent for his invention titled "Semi-synthetic meningococcal conjugate vaccine." This groundbreaking invention pertains to a novel vaccine comprising a synthetic oligosaccharide conjugated to a carrier protein. It also includes a unique synthetic meningococcal oligosaccharide and outlines a process for its preparation, showcasing his dedication to advancing vaccine technology.

Career Highlights: Eswara Kowlakuntla is currently employed at Biological E Limited, a reputable organization in the pharmaceutical sector. His role in developing life-saving vaccines exemplifies his commitment to improving healthcare outcomes through scientific innovation.

Collaborations: Throughout his career, Eswara has collaborated with talented professionals, including Akshay Goel and Santosh Renukuntla. These partnerships reflect an environment of collaborative innovation and knowledge exchange, crucial for driving advancements in the field.

Conclusion: Eswara Kowlakuntla stands out as a prominent inventor whose contributions to vaccine development are commendable. His work on the semi-synthetic meningococcal conjugate vaccine is not only innovative but also vital for addressing public health challenges. With ongoing collaborations and a focus on research, he continues to make significant strides in the field of immunology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…